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Although most primary health care teams in the U.K. now offer proactive care for patients with asthma, 
there is relatively little published evidence showing the effectiveness of such innovations. This may be due 
in part to lack of targeting of extra care towards those most in need. Therefore, to demonstrate the 
benefits of targeted nurse-run asthma clinic care in a seven-partner general practice in a mixed urban and 
rural area of North Lincolnshire in the east of England, a cohort of 173 patients, with asthma selected 
predominantly by having high morbidity in a postal survey, completed 12 months follow-up in a 
nurse-run asthma clinic. A longitudinal comparison was conducted in terms of: changes in morbidity 
index category, inhaler technique score, knowledge score, use of inhaled steroids, use of salmeterol, 
method of administration of &agonist medication and frequent use of peak flow meters. The number 
with high morbidity fell from 123 (71.1%) at the initial consultation to 14 (8.1%) at the 12-month review. 
Those with full marks on inhaler technique rose from 28 (16.2%) to 142 (82.1%), and with full marks on 
asthma knowledge rose from 7(4.0%) to 98 (56.6%). The numbers of patients using inhaled steroids and 
salmeterol rose from 127 (73.4%) to 171 (98.9%) and from 5 (2.9%) to 35 (20.2%), resljectively. The 
preferred inhaler device for &bronchodilator medication changed from metered dose aerosol to dry 
powder. Regular use of peak flow meters in 157 subjects aged 5 years and over rose from 43 (27.4%) to 
116 (73.9%). These data clearly demonstrate the benefits of targeted proactive nurse-run asthma care in 
terms of reduced morbidity for patients. The authors recommend the morbidity index targeting concept 
to other primary health care teams. 
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Introduction 
Since 1990, when the then new contact for general 
practice established the concept of remuneration for 
health promotion clinics (l), most primary health 
care teams in the U.K. have offered some form of 
proactive care for patients with asthma. In the major- 
ity of cases, this has been established by developing 
an extended role for practice nurses along the lines 
pioneered by Barnes and Pearson at Stratford-upon- 
Avon, U.K. (2,3). Despite this near ubiquity, 
scientifically rigorous evidence clearly showing the 
effectiveness of this approach has been very hard to 
come by and concerns have been expressed at the 
lack of formally assessed training experienced by a 
significant minority of nurses attempting to provide 
proactive asthma care (4). Indeed, one of the few 
formally constructed randomized controlled trials of 
nurse-run asthma care in the U.K. not only proved 
inconclusive, but also suggested that such a method- 
ological approach may be no longer possible (5). 
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A further problem complicating the assessment 
of nurse-run asthma care has been the relative lack 
of suitable pragmatic outcome measures for use in 
primary care. A number of scientifically validated 
instruments have been constructed. (6-S), but they 
are likely to be too long for use in routine practice. A 
group set up by the U.K. Department of Health has 
recently considered suitable pragmatic outcome 
measures for asthma care in the community (unpubl. 
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The index is based on the answers to the following three questions: 
1. Are you in a wheezy or asthmatic condition at least once per week? 
2. Have you had time off work or school in the last year because of your 
asthma? 
3. Do you suffer from attacks of wheezing during the night? 
‘NO’ answers to all questions= LOW morbidity 
One ‘YES’ answer = MEDIUM morbidity 
Two or more ‘YES’ answers=HIGH morbidity 
FIG. 1. The Jones Morbidity Index (9). 
to date), and has acknowledged the utility of simple 
measures such as the three-category Jones morbidity 
index developed in Southampton, U.K. (9,lO). 
This project, located in the routine of everyday 
general practice, has therefore used the Jones morbid- 
ity index to conduct a before and after comparison 
for patients with asthma attending a nurse-run 
asthma clinic set up on the Stratford-upon-Avon 
model. 
Methods 
Central Surgery is a seven-partner general practice 
serving a population of 1.5 210 people in a mixed 
urban and rural area of North Lincolnshire in the 
east of England. Before starting a nurse-run asthma 
clinic service, an asthma register was established 
based on repeat prescribing records. All patients 
using, as prescribed, drugs recommended for asthma 
in the respiratory section of the British National 
Formulary were sent a questionnaire comprising the 
previously validated Jones morbidity index (see Fig. 
1) (9). A second mailing was sent to non-responders. 
All patients in the high morbidity category (from the 
initial questionnaire survey) were invited to attend the 
clinic, together with all those discharged from hospi- 
tal following an acute attack of asthma, all those 
needing emergency nebulization, all new patients and 
some not meeting these criteria by request from other 
GPs within the practice. 
Four asthma clinic sessions per week are run by 
two practice nurses (SH and AA), both of whom have 
the National Asthma Training Centre diploma in 
asthma management and one (SH) also has the 
diploma in the management of chronic obstructive 
pulmonary disease. A general practitioner (JD) con- 
ducts a routine surgery at the same time as these 
sessions and is easily accessible for advice, script 
signing, etc. Duration of appointments varies from 15 
to 30 min depending on the requirements of indi- 
vidual patients. Stable patients are reviewed at 
6-monthly intervals (occasionally yearly, if very 
mild); frequency of review for those not considered 
stable varies with individual need. 
At first appointments, the purpose of the clinic is 
explained to patients and a comprehensive history is 
taken, including occupational aspects. Height, weight 
and lung function (usually peak flow) are measured, 
and all attenders are seen by the GP prior to decisions 
about any necessary further investigations and the 
formulation and recording of an appropriate treat- 
ment plan. All patients are provided with suitable 
preprinted educational material and are offered a 
mini-Wright peak flow meter for use prior to other 
consultations. At this and all subsequent consul- 
tations, the following data are also recorded: Jones 
morbidity index category (9) Hilton five-point 
inhaler technique score (11) and knowledge score 
(on a scale of O-3 in response to a short interview, 
with one point each for a reasonable knowledge of 
the nature of the disease, the difference between 
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TABLE 1. Changes in morbidity index, inhaler technique and knowledge scores (n = 173) 
Variable 
Initial consultation 6-month review 
No. (%) No. (%) 
12-month review 
No. (%) 
Morbidity index score 
Low 
Medium 
High 
Inhaler technique score 
0 
1 
2 
3 
4 
5 
Knowledge score 
0 
1 
2 
3 
17 (98) 101 (58.4) 116 (67.1) 
33 (19.1) 48 (27.7) 43 (24.9) 
123 (71.1) 24 (13.9) 14 (8.1) 
22 (12.7) 0 0 
14 (8.1) 0 0 
37 (21.4) 5 (2.9) 0 
46 (26.6) 8 (4.6) 5 (2.9) 
26 (15.0) 31 (17.9) 26 (15.0) 
28 (16.2) 129 (74.6) 142 (82.1) 
37 (21.4) 2 (1.2) 2 (1.2) 
92 (53.2) 15 (8.7) 5 (2.9) 
37 (21.4) 87 (50.3) 68 (39.3) 
7 (4.0) 69 (39.9) 98 (56.6) 
preventers and relievers, and the recognition of 
deterioration and what to do about it). At each 
review, a clinical judgement of adequacy of disease 
control is made by the nurses, and further education 
given as necessary. Particular emphasis is made on 
good inhaler technique. Inhaler devices and drug 
doses are changed without reference to the GP, but 
drug changes are discussed individually. 
Treatment strategies follow the 1993 British 
Thoracic Society (BTS) guidelines (12) except for rare 
initiation of cromoglycate therapy in children and a 
recent tendency to use salmeterol at moderate as 
opposed to high doses of inhaled steroids. Not all 
patients have written management plans; where they 
do, information is written on the individual’s peak 
flow record card. Initiation of such plans depends on 
the individual’s willingness to measure peak flow 
regularly and their competence in doing so. Referrals 
to hospital are rare, but occur where there is diag- 
nostic doubt, poor responses to treatment or occu- 
pational asthma is considered possible. Treatment 
advice to patients is usually available by telephone 
and all five practice nurses can manage acute episodes 
according to the BTS guidelines. A district nurse 
with the asthma diploma carries out domiciliary 
assessments on older patients. 
Descriptive data from the clinic from initial consul- 
tations, 6-month and 12-month reviews are presented 
with McNemar’s tests as appropriate. The primary 
outcome measure of the study is change in Jones 
morbidity index category, with secondary outcome 
process measures being changes in inhaler technique 
score, knowledge score, use of inhaled steroids, use of 
salmeterol, method of administration of &agonist 
medication and number making frequent use of peak 
flow meters. The Jones morbidity index data shown 
are from the first and subsequent clinic attendances, 
and not from the initial questionnaire, unless 
otherwise indicated. 
All those initially in the high morbidity cohort were 
sent a further questionnaire after 12 months so that 
those attending the asthma clinic could be compared 
with those attending only their general practitioner. 
Results 
Six hundred and fifteen questionnaires were sent out 
in the initial survey, from which 510 (83%) were 
returned. No data were gathered on those who did 
not respond to the questionnaire. Two hundred and 
sixty-five of these (52%) were in the high morbidity 
category (23% were aged O-16 years, 52% 17-65 years 
and 25% 66 or over). One hundred and seventy-eight 
patients (67%) expressed an interest in attending the 
clinic. Up to the end of March 1996, 173 clinic 
attenders had been assessed 12 months after their first 
clinic attendance, although this number did include 
some not initially in the high morbidity group (as 
described in Methods). 
TABLE 2. Changes in therapy and inhaler device (n= 173) 
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Variable 
Initial consultation 12-month review 
No. (%) No. (55) 
Inhaled steroid use 
Salmeterol use 
Inhaler device use for &agonist 
Metered dose aerosol 
Dry powder 
Spacer 
Oral 
Nebule 
None 
127 (73.4) 171 (98.9) 
5 (2.9) 35 (20.2) 
80 (46.2) 15 (8.7) 
48 (27.8) 103 (59.5) 
29 (16.8) 55 (31.8) 
8 (4.6) 0 
1 (0.6) 0 
7 (4.0) 
The cohort comprised 88 males and 85 females, 
and had a median age of 42 years (range 2-81 years). 
The number with high morbidity fell from 123 
(71.1%) at the initial consultation to 14 (8.1%) at the 
12-month review (see Table 1). This change is clini- 
cally and statistically highly significant [McNemar’s 
test with correction for continuity 105.1, P<O.OOOl, 
difference in proportions 0.63% (95% confidence 
interval for difference 0.56-0.70)]. Similarly, the 
number with full marks on inhaler technique rose 
from 28 (16.2%) to 142 (82.1%), and the number with 
full marks on asthma knowledge rose from 7 (4.0%) 
to 98 (56.6%). The numbers of patients using inhaled 
steroids and salmeterol rose from 127 (73.4%) to 171 
(98.9%) and from 5 (2.9%) to 35 (20.2%), respectively 
(see Table 2). The preferred inhaler device for 
&bronchodilator medication changed from metered 
dose aerosol to dry powder. 
Regular use of peak flow meters in those 157 
subjects aged 5 years and over in the cohort rose from 
43 (27.4%) at first consultation to 116 (73.9%) at the 
12-month review. 
Data on 77 patients who had attended the clinic at 
least once were compared with 134 non-attenders 
from the original high morbidity cohort. After 12 
months, 21 attenders had medium morbidity and 19 
had low (52% had improved). Twenty-seven non- 
attenders had medium morbidity and 18 had low 
(30% had improved). The percentages of attenders 
and non-attenders on anti-inflammatory therapy 
after 12 months were 92 and 55%, respectively. 
Discussion 
The data gathered in this study clearly demonstrate 
the benefits of proactive asthma care in terms of 
reduced morbidity for patients. This is a true outcome 
measure of care, rather than the more usually 
reported process measures - although evidence of 
improvement was also noted in these areas. Consid- 
ering that the vast majority of general practitioners 
in the U.K. have signed up to receive additional 
payments for asthma care under the chronic disease 
management programme, this demonstration of 
effectiveness is surely most’ welcome. 
There are, however, a number of significant 
methodological considerations which necessarily 
serve to reduce the rigour of this study, and thus must 
raise some caution in the interpretation of its results. 
First and foremost among these is the uncontrolled 
nature of the research, relying on before and after 
comparisons to establish effectiveness. It is obviously 
preferable to conduct formal randomized controlled 
trials, even when the organizational aspects of care 
are being tested, but most general practitioners in the 
U.K. would not now feel able to randomize patients 
with asthma into a group not receiving any proactive 
care, and indeed many subjects with asthma will by 
now have had some experience of such care. As said 
earlier, a definitive formal randomized controlled trial 
of nurse-run asthma care in the setting of U.K. 
general practice is probably no longer possible (5). 
Theoretically, a study could be set up randomizing 
patients with asthma to exclusively doctor-led or to 
exclusively nurse-led care with assessments of both 
effectiveness and cost-effectiveness, but this method- 
ology would run contrary to the teamwork emphasis 
practised by most primary health care teams. 
The second methodological consideration concerns 
the sample size employed in this study. The data 
presented are from just one practice and concern a 
single cohort of under 200 patients. While again it 
would have been preferable to have conducted a 
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larger scale project across a greater number of prac- 
tices, this would have reduced the continuity of the 
intervention, since each practice would have had 
differing views on case definition and the nature and 
structure of the intervention, and have added consid- 
erably to the organizational complexity and cost of 
the investigation. Well-conducted and documented 
single-practice studies are preferable to larger but 
more loosely regulated investigations. 
The third consideration of importance is the nature 
and use of the main outcome variable, namely the 
Jones morbidity index. The index was set up to be a 
simple, pragmatic instrument of use in routine gen- 
eral practice (9) and thus is much less complex than 
other outcome measures (6-8). However, it has been 
shown to be significantly associated with diurnal 
variation in peak flow (9) which is thought to be a 
sensitive indicator of disease activity. In the absence 
of a gold standard for measuring asthma status in the 
setting of routine general practice, it appears accept- 
able to use the index as an outcome measure in this 
study. More research is, however, needed to compare 
this index to other asthma outcomes instruments, 
such as the new short form St. George’s questionnaire 
(13) the Juniper et al. questionnaire (6), the pair of 
five item questionnaires by Steen et al. (8), and “b, 
Hyland’s ‘Living ,with, Asthma’ questionnaire which 
focuses on the degree of bother caused by the disease 
(14). 
The index has been used in two ways in this 
research. Firstly, it was used as a postal screen to 
identify a cohort of patients with asthma with high 
morbidity who were to be invited to attend the 
nurse-run asthma clinic. Secondly, it was used to 
assess the outcome of clinic attendance. It should be 
emphasized that the index data from the postal screen 
were not part of the outcome study, since the index 
questions were repeated at first clinic attendance, and 
it is these latter data that form the baseline in our 
results. The magnitude of the changes observed in the 
morbidity index categories makes it unlikely that 
regression towards the mean is the sole explanation 
for the changes observed, although the absence of a 
control group makes interpretation more difficult. 
More than three observation points would have per- 
mitted a more detailed time scores analysis, but time 
and resource pressures.did not allow this. This point 
is reinforced by other, as yet unpublished, experience 
with the morbidity index which shows that in another 
single practice sample of 570 subjects, 57% of initial 
morbidity , classifications were unchanged after 12 
months during which no innovations in care were 
introduced. Those 43% of classifications which did 
change were symmetrical - 22% improved and 21% 
worsened. 
The initial categorization of patients into the three 
morbidity groups was done at one given point in 
time. Whilst simple and pragmatic, the predictive 
value of the high morbidity designation still needs to 
be fully established. Other research in progress will 
hopefully clarify this point further. The concept of 
increasing efficiency of care (and possibly reducing 
doctor and nurse workload) by targeting on the basis 
of Jones morbidity index category is attractive, 
although other means of targeting (as yet untested in 
this way) may be possibly more effective. However, it 
must be acknowledged that patients with asthma in 
the medium or low categories are still at some risk of 
severe and potentially fatal acute exacerbations of the 
disease. All those with asthma must know at least the 
following minimum about their condition: the pur- 
pose of their prescribed therapies, the frequency with 
which they are to be used and, most importantly, the 
action they need to take if their treatment appears not 
to be working. It is possible, though unlikely, that this 
study’s demonstrated health gains for clinic attenders 
might have been achieved at the cost of worsening 
morbidity in non-attenders. Follow-up of all the 
asthma patients in the practice could, have explored 
this possibility. 
The evaluation could have been reinforced by 
either peak flow diaries kept before each clinic attend- 
ance (or more formal lung function tests), or by the 
inclusion of measures of patient satisfaction with 
nurse-run- clinic-based care compared with more 
traditional models, but these were beyond the scope 
of these investigations. 
Having raised and discussed these points, the 
authors would argue that, while these data would not 
be sufficient to justify the widespread introduction of 
nurse-run asthma care into a system of primary care 
devoid of such innovations, these results do give a 
very much needed demonstration of effectiveness in a 
routine clinical system making widespread use of 
nurses with extended roles in asthma care. This is 
particularly evident from the comparison of attenders 
and non-attenders from the original high morbidity 
cohort. The questionnaire non-responders must not 
be forgotten, however, in applying these promising 
results - previous research has indicated that they 
have, if anything, more morbidity than respondents 
and thus may be especially in need of opportunistic 
asthma review (10). 
Why have such impressive results been obtained in 
this study when other published work has mostly 
been more equivocal? Firstly, two previous studies 
which did not produce significant changes in out- 
comes found that, despite introducing a clinic system, 
the numbers of patients on inhaled steroid therapy 
did not increase (5,15), whereas they did do so in this 
study. Meticulous attention was also paid in inhaler 
technique and device selection in this study, pre- 
sumably leading to a greater delivery of anti- 
inflammatory therapy to the airways of patients. 
After attending the clinic, many more patients were 
prescribed dry powder devices. Where poor perform- 
ance with metered dose inhalers had been demon- 
strated by the scoring system, and an electronic device 
and education did not produce an improvement, 
these devices were usually preferred by patients. Their 
ease of use and rapid learning time in busy clinic 
settings, together with reassuring evidence of lung 
deposition, and the benefits of an indication of 
impending emptiness reinforce this preference. The 
increased prescribing costs incurred by using these 
devices for bronchodilators are likely to be offset by 
reductions in the non-drug costs of asthma. 
Secondly, the cohort of patients invited to receive 
nurse-run asthma care in the clinic was selected on the 
basis of self-expressed morbidity. The intervention in 
the study by Jones and Mullee was directed at an age 
cohort in the first instance (8) -this probably 
reduced the chances of demonstrating change. The 
study of Charlton et al. which did demonstrate ben- 
eficial changes in outcomes was based on a cohort 
already taking inhaled steroids (16). The prevalence 
of asthma, at around 10% of the population, is too 
large for cost-effective proactive care to be offered to 
all this number - contrary to the situation with other 
chronic diseases such as diabetes-and it seems 
intuitively right to target additional care on those 
with most evidence of need. Furthermore, the pack- 
age of care offered to patients in the present study 
included the initial survey - this approach may well 
be an important element in stimulating attendance at 
the clinic. Patient-education programmes offered to 
non-targeted cohorts have been shown to improve 
knowledge but not morbidity (17). 
What can be learned from these results? The 
authors feel that the data presented are important for 
a number of reasons. Firstly, the magnitude of the 
reduction in morbidity demonstrated is an important 
justification for the continued involvement of trained 
asthma nurses in primary care. Considering the bur- 
den of morbidity suffered by subjects with asthma (9), 
and how many practices are claiming public money to 
provide better asthma care, this message is timely 
indeed. Secondly, targeting proactive care to those 
people with significant asthma morbidity appears to 
be a critical part of making this exercise more effec- 
tive. No proper health economics evaluation was part 
of this study, but it is clearly good sense to relate 
proactive care to health need. Many practices with 
otherwise good asthma care systems may be being 
wasteful and thus inefficient in this regard. Thirdly, 
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the authors’ clinic activities have involved consider- 
able attention to detail in simple areas such as inhaler 
technique and type of device. Again, effectiveness 
may well depend on such meticulousness. 
The relatively small numbers of patients seen in this 
study do not allow further comment on which parts 
of the nurses’ asthma care package are most effective. 
For instance, improvement in outcomes may depend 
most on the doses of inhaled steroids prescribed, or 
on the type of inhaler device employed, or on the use 
of peak flow meters and charts. However, the message 
that the interaction of a general practitioner and 
nurses in the way described produces marked 
improvements in morbidity remains important - 
other research may be able to tackle the issue of the 
effectiveness of individual components of nurse-run 
asthma care. 
In conclusion, therefore, the authors feel that this 
group of patients with asthma in North Lincolnshire 
has derived considerable benefit from this nurse-run 
asthma care system, and the authors are happy to 
recommend the morbidity index targeting concept 
to other primary health care teams. 
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